YKL-06-061
DC10778 (CAS:2172617-15-9 )

(Based on popularity)
 |
Size |
Price |
Availability |
100mg |
USD 550 |
In stock |
250mg |
USD 950 |
In stock |
1g |
USD 1900 |
In stock |
|
We match the best price and quality on market. |
|
|
|
Email: order@dcchemicals.com
Tel: +86-21-58447131
Fax:+86-21-61642470 |
|
Fields of Application :
YKL-06-061 is a potent and selective SIK (salt-inducible kinase) inhibitor.
CAS Number: |
2172617-15-9 |
Purity: |
>98% |
Molecular Weight: |
527.3 |
Molecular Formula: |
C30H37N7O2 |
Quality Control: HPLC¡¢NMR¡¢ LC/MS(Please contact us to get the QC report)
Synonyms: |
YKL-06-061; YKL06-061; YKL 06-061; YKL-06061; YKL06061; YKL 06061 |
Chemical Name: |
1-Cyclobutyl-3-(2,6-dimethylphenyl)-7-(2-methoxy-4-(4-methylpiperazin-1-yl)phenylamino)-3,4-dihydropyrimido[4,5-d]pyrimidin-2(1H)-one |
Storage: |
4 Degree for 1 year, -20 degree for more than 2 years |
Note: Products for research use only, not for human use
Description:
YKL-06-061 is a potent and selective SIK (salt-inducible kinase) inhibitor. Salt-inducible kinases (SIKs) are related to the metabolic regulator AMP-activated protein kinase (AMPK). Salt-inducible kinase induces cytoplasmic histone deacetylase 4 to promote vascular calcification. Pharmacologic inhibition of SIK sends HDAC4 to the nucleus and inhibits the calcification process in VSMCs, aortic rings, and in vivo In the cytoplasm, HDAC4 binds and its activity depends on the adaptor protein ENIGMA (Pdlim7) to promote vascular calcification.
References:
O=C1N(C2CCC2)C3=NC(NC4=CC=C(N5CCN(C)CC5)C=C4OC)=NC=C3CN1C6=C(C)C=CC=C6C